Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

GREENGUARD's First Exhibit at HEALTHCARE DESIGN.10 to Help Architects and Designers Specify Healthier Products More Easily and Efficiently

November 2, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Architects and designers who visit the GREENGUARD Environmental Institute 's first-ever HEALTHCARE DESIGN.10 exhibit next week will have the opportunity to learn how low-emitting products and materials can help create healthier, more...

TOPICS:

GeNO LLC Submits Investigational New Drug Application for Its NITROsylâ„¢ Inhaled Nitric Oxide System to Treat Chronic Pulmonary Hypertension

November 2, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

COCOA, Fla., Nov. 2, 2010 /- GeNO LLC ( www.genollc.com ) a privately held, advanced development-stage technology company announced today that it has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for the GeNO NITROsyl (Inhaled Nitric...

TOPICS:

RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs

November 2, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Nov. 2, 2010 /- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has acquired a majority interest in Salter Labs ("Salter").  Founded in 1976 by Peter...

TOPICS:
Advertisement

Allegheny General Hospital Study Suggests Use of Image Guided Intensity Modulated Radiation Therapy Reduces Risk of Impotency in Men Needing Radiation after Prostate Cancer Su...

November 2, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Men battling prostate cancer who receive Image Guided Intensity Modulated Radiation Therapy after undergoing prostatectomy have an excellent chance of retaining sexual function, according to a study by Allegheny General Hospital (AGH)...

TOPICS:

Class I Medical Device Recall: Medtronic Octopus Nuvo Tissue Stabilizer, Model TSMICS1

November 2, 2010 10:30 am | by U.S. Food & Drug Administration | News | Comments

This device stabilizes and minimizes the motion of selected areas of the beating heart during minimally invasive cardiac procedures while directly visualizing the heart through a small cut in the chest cavity.

TOPICS:

Los Angeles-Based M & A Expert Expands Firm's Transactional Practice

November 2, 2010 9:46 am | by The Associated Press | News | Comments

Jeryl A. Bowers has joined the Los Angeles/Century City office of Sheppard, Mullin, Richter & Hampton LLP as a partner in the firm's Corporate practice group. Bowers most recently was a partner at K&L Gates in Los Angeles.Bowers concentrates his practice in mergers and acquisitions and ...

Tenet Healthcare 3Q profit surges on tax benefit(2)

November 2, 2010 9:46 am | by The Associated Press | News | Comments

Hospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the third quarter on $981 million in deferred tax benefits.The company earned $932 million, or $1.68 per share, compared with a loss of $3 million, or a penny per share, during the same period a year prior. Revenue...

Tenet Healthcare 3Q profit surges on tax benefit

November 2, 2010 9:45 am | News | Comments

Hospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the third quarter on $981 million in deferred tax benefits.The company earned $932 million, or $1.68 per share, compared with a loss of $3 million, or a penny per share, during the same period a year prior. Revenue...

Advertisement

BioScrip 3Q profit falls 66 pct; new CEO announced

November 2, 2010 8:45 am | by The Associated Press | News | Comments

BioScrip Inc.'s net income fell by two-thirds in the third quarter, the pharmacy benefits manager said Tuesday, on a surge in operating expenses following the buyout of Critical Homecare Solutions in March.Meanwhile, the company said Richard M. Smith will replace Richard H. Friedman as CEO on...

Global map of the sickle cell gene supports 'malaria hypothesis'

November 2, 2010 8:34 am | by EurekAlert | News | Comments

(Wellcome Trust) At a global scale, the sickle cell gene is most commonly found in areas with historically high levels of malaria, adding geographical support to the hypothesis that the gene, whilst potentially deadly, avoids disappearing through natural selection by providing...

TOPICS:

Aging with grace: Health care delivery model yields improved outcomes and lower costs

November 2, 2010 8:34 am | by EurekAlert | News | Comments

(Indiana University School of Medicine) GRACE, a model program developed at Indiana University to provide care to low-income older adults in their homes, has earned recognition for its effective approach and cost-saving benefits in Nov. 3 issue of JAMA.

TOPICS:

Skilled Healthcare shares rise on results, outlook

November 2, 2010 7:46 am | by The Associated Press | News | Comments

Shares of Skilled Healthcare Group Inc. surged Tuesday after the company reported a boost in third-quarter revenue from its long-term care business and boosted its full-year guidance.The stock rose 81 cents, or 21 percent, to $4.74 in morning trading.Late Monday, the Foothill Ranch,...

Study provides treatment hope for long term effects of brain trauma

November 2, 2010 6:38 am | by EurekAlert | News | Comments

(University of Melbourne) Brain damage continues to develop and evolve for months after a traumatic brain injury, revealing a potential target for treatments to improve brain trauma, new research led by the University of Melbourne Australia, has found.

TOPICS:

Endologix Announces First Clinical Implant of Ventanaâ„¢ Stent Graft

November 2, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 2, 2010 /- Endologix, Inc. (Nasdaq: ELGX ), developer of minimally invasive treatments for aortic disorders, announced today the first clinical implant of the Company's Ventana™ fenestrated stent graft at Auckland City Hospital in Auckland, New Zealand....

TOPICS:

Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India

November 2, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

HYDERABAD, India, Nov. 2, 2010 /- Advanced cancer treatments across India will become more widely available with the order of four state-of-the-art Varian Medical Systems (NYSE: VAR ) medical linear accelerators by Global Hospitals, one of the nation's leading private hospital groups....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading